Ethnopharmacological Relevance. Cryptolepis sanguinolenta is a scrambling thin-stemmed shrub found in Africa. Traditionally in West Africa, it is employed in the treatment of malaria, diarrhea, and respiratory conditions. This review discusses the traditional importance as well as the phytochemical, ethnomedical, pharmacological, and toxicological importance of this plant. Materials and Methods. Excerpta Medica Database, Google Scholar, Springer, and PubMed Central were the electronic databases used to search for and filter primary studies on Cryptolepis sanguinolenta. Results. The detailed review of various studies conducted on C. sanguinolenta and some of its constituents gives an important body of proof of its potential therapeutic benef...
Medicinal plants are key in the treatment of malaria in many developing countries. This study report...
The activity of cryptolepine hydrochloride, a salt of the main indoloquinoline alkaloid from the Wes...
Natural products are acknowledged sources of novel compounds for use in the treatment of diseases ...
Cryptolepis sanguinolenta (Lindl.) Schltr (Periplocaceae), has a longstanding traditional use in the...
The roots of Cryptolepis sanguinolenta have been investigated for their chemical composition since 1...
The present study investigated the phytochemistry and anti-inflammatory activity of methanolic root ...
Cryptolepis sanguinolenta (Cs) is a medicinal plant, indigenous to the West Africa sub-region and ha...
Cryptolepine is the main alkaloid of Cryptolepis sanguinolenta (Lindl.) Schlechter, a plant used in ...
Acute and sub-acute oral toxicity assessment of the aqueous root extract of Cryptolepis sanguinolent...
Objective: Extracts from various morphological parts of Cryptolepis sanguinolenta are widely used tr...
Sanguinaria canadensis, also known as bloodroot, is a traditional medicine used by Native Americans ...
Objectives: To study were to formulate the ethanolic extract of Cryptolepis sanguinolenta root into ...
Sanguinaria canadensis, also known as bloodroot, is a traditional medicine used by Native Americans ...
Sanguinaria canadensis, also known as bloodroot, is a traditional medicine used by Native Americans ...
Cryptolepis sanguinolenta (Lindl.) Schlt., the main source of cryptolepine alkaloid, is intensively ...
Medicinal plants are key in the treatment of malaria in many developing countries. This study report...
The activity of cryptolepine hydrochloride, a salt of the main indoloquinoline alkaloid from the Wes...
Natural products are acknowledged sources of novel compounds for use in the treatment of diseases ...
Cryptolepis sanguinolenta (Lindl.) Schltr (Periplocaceae), has a longstanding traditional use in the...
The roots of Cryptolepis sanguinolenta have been investigated for their chemical composition since 1...
The present study investigated the phytochemistry and anti-inflammatory activity of methanolic root ...
Cryptolepis sanguinolenta (Cs) is a medicinal plant, indigenous to the West Africa sub-region and ha...
Cryptolepine is the main alkaloid of Cryptolepis sanguinolenta (Lindl.) Schlechter, a plant used in ...
Acute and sub-acute oral toxicity assessment of the aqueous root extract of Cryptolepis sanguinolent...
Objective: Extracts from various morphological parts of Cryptolepis sanguinolenta are widely used tr...
Sanguinaria canadensis, also known as bloodroot, is a traditional medicine used by Native Americans ...
Objectives: To study were to formulate the ethanolic extract of Cryptolepis sanguinolenta root into ...
Sanguinaria canadensis, also known as bloodroot, is a traditional medicine used by Native Americans ...
Sanguinaria canadensis, also known as bloodroot, is a traditional medicine used by Native Americans ...
Cryptolepis sanguinolenta (Lindl.) Schlt., the main source of cryptolepine alkaloid, is intensively ...
Medicinal plants are key in the treatment of malaria in many developing countries. This study report...
The activity of cryptolepine hydrochloride, a salt of the main indoloquinoline alkaloid from the Wes...
Natural products are acknowledged sources of novel compounds for use in the treatment of diseases ...